Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies

High Tide

Market Cap: CA$280.3m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Green Thumb Industries

Market Cap: CA$2.1b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Cresco Labs

Market Cap: CA$476.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Decibel Cannabis

Market Cap: CA$63.5m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Curaleaf Holdings

Market Cap: CA$3.4b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Planet 13 Holdings

Market Cap: CA$55.3m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Aurora Cannabis

Market Cap: CA$257.1m

Engages in the production, distribution, and sale of cannabis products in Canada and internationally.

Jushi Holdings

Market Cap: CA$82.3m

Engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States.

Novo Nordisk

Market Cap: CA$1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

MariMed

Market Cap: CA$27.3m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

Medexus Pharmaceuticals

Market Cap: CA$160.2m

Operates as a pharmaceutical company in Canada and the United States.

Organigram Global

Market Cap: CA$192.9m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

TerrAscend

Market Cap: CA$272.3m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Rubicon Organics

Market Cap: CA$37.2m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Novo Nordisk

Market Cap: CA$1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Auxly Cannabis Group

Market Cap: CA$288.8m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.

Bausch Health Companies

Market Cap: CA$2.3b

Operates as a diversified specialty pharmaceutical and medical device company.

SOL Global Investments

Market Cap: CA$1.1m

A private equity firm specializing in emerging growth.

Cronos Group

Market Cap: CA$1.6b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Avant Brands

Market Cap: CA$8.7m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Novartis

Market Cap: CA$239.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Thermo Fisher Scientific

Market Cap: CA$219.6b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Vireo Growth

Market Cap: CA$705.1m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

Gilead Sciences

Market Cap: CA$165.2b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Fennec Pharmaceuticals

Market Cap: CA$402.1m

Operates as a commercial stage biopharmaceutical company in the United States.

Verano Holdings

Market Cap: CA$558.2m

Engages in the cannabis business in the United States.

CordovaCann

Market Cap: CA$4.4m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

Roche Holding

Market Cap: CA$293.2b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Vext Science

Market Cap: CA$63.2m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Sanofi

Market Cap: CA$90.2b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Amgen

Market Cap: CA$222.2b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

SNDL

Market Cap: CA$305.9m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally.

Cipher Pharmaceuticals

Market Cap: CA$446.0m

Operates as a specialty pharmaceutical company in Canada.

BioSyent

Market Cap: CA$171.6m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Apotex Health

Market Cap: CA$8.5b

Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

1933 Industries

Market Cap: CA$5.2m

Engages in the cultivation, extraction, and production of cannabis products in the United States.